joaquín llacer - corifolitropina en la paciente habitual - ii simposio reproducción asistida...

8/12/2019 Joaqun Llacer - Corifolitropina en La Paciente Habitual - II Simposio Reproduccin Asistida Quirn

1/65

Onfque Mmkar FpfrhkhnQehbfb Gabhkhef Zaprnbukthvf

Hesthtutn Jarefjau

!"#$%"&$'#"($)* ,) &* (*-$,)', .*/$'0*&

@ [email protected]

HH [hgpnshn. Zaprnbukkhe FshsthbfIrupn Dnsphtfmfrhn Vuhre

Gfbrhb:0-:6 cajrarn :062


2/65

! # $ % & ' ( ) * !+


3/65

,-./06:;2139- 4:8: ?


4/65

713:359-

,-./06:;2139- 4:8: ?:@250:6

6*-$,)', :*/$'0*&


5/65

;")*)',2

1*3*9,2(0,2'*

,-./06:;2139- 4:8: ?:@250:6

6*-$,)', :*/$'0*&


6/65

;")*)',2

1*3*

9,2(0,2'*

486

,-./06:;2139- 4:8: ?:@250:6FFFFFFFF>:@250:6

6*-$,)', :*/$'0*&


7/65

J>KB ACK ?IDHK 7, ,OL


8/65

?2


9/65

?2


10/65NP4VZZ[[[R2Q-S025R;1/Z69;5089Y95:26Z&*Z:85ST81/SN95981X93925_S51S23Y2\2Y0:62-:.13S1TS589:5/935

J

K

J

?2


11/65

BA *C"2 AI DHO D*-'"# L0/M#$-"

9DG )"#=*& GE: /*3*

NP4VZZ[[[R2Q-S025R;1/Z69;5089Y95:26Z&*Z:85ST81/SN95981X93925_S51S23Y2\2Y0:62-:.13S1TS589:5/935

?2


12/65


BN *C"2 PI DHO ?)@"=,'#$"2$2

AI -$-&" V*#Z" PPK[ B 8R"Q GE: *&'*

?2


13/65


BJ *C"2 AI DHO ?8;

8"%"#,-=S* Y)$&*',#*& GE: ("# ,)-$=* @, &* =,@$*

?2


14/65

?2


15/65

J]A, WAOGKHIO GAKC7I ,OL


16/65

8/3,


17/65

T0=/,# "% ,ZZ2 *)@ &$R, /$#'. $) HOD '#,*'=,)'Q 40)X*#* ,' *&Q :0= 9,(#"@ P_AA

8/3,


18/65

H)',#)*


19/65

8/3,


20/65

8/3,


21/65

D,#


22/65

8/3,


23/65

8/3,


24/65

?2


25/65

V* E*#-* GW 6*(*&," ?W ^#$2,)@$ OW G#Z,)'" !W ^$0&$)$ 4W O"&(, GQ ;,R,&"(=,)' "% *

)"="Z#*= /*2,@ ") =*#X,#2 "% "R*#$*) #,2,#R, %"# '., $)@$R$@0*&$2**@*F


26/65

Y)* ,2


27/65

J,O ,MIC=K ACK >,DDKH


28/65

8?O>

! # $ % & ' ( ) * !+

K35:X132-5: U3D>

NGUG182T1662581423: :6T:

?&")R*]

9,0)$7) @, &*)>*=$,)'"E0#-$* AN @, 30)$" @, P_AA

JKEIDLK KMUI CA,=I D,M,=KCL,F


29/65

Nvar 10% ncpfthaets wara

knekareabfjnut samc-heoakthei

60%warawnrrhab fjnutfbghehstarhei

tda knrraktbnsa

21%ncpfthaetsrapnrtab

dfvhei gfbafe arrnr

:8%nc tdasapfthaets bhbent rapnrtparkahvabarrnrs tn

kmhehk

!"="@$@*@ (*#* &* (*-$,)',


30/65

9,a0,)* GQ 9,(#"@ 1$"=,@ 8)&$),Q P_ABQ

?R*&0*" JkWc i JBWc i T4

L*2* @, $=(&*)'*-$7) BjWk i BkWk i T4

4*


31/65

J,OL


32/65

?l-*-$*


33/65

^)9: *)'*Z")$2' dZ*)$#,&$g _QPK =Ze@o@*\ K '.#"0Z. @*\ "% .!^

4


34/65

ZFEBNGH_FBF[

AK_j 6G!H?TL?4

! E0&


35/65

Kn-Njoathvn Prhekhpfm? Nvnkhtns Zakuparfbns

Knrhcnmmhtrnphe Fmcf

610 !i

Puraine

:00 HQ/b

Bhcaraekhf Asthgfbf

FENSF (81% KH)

(e7913) (e7910)

E ba nvnkhtns

rakuparfbns6

6;.9 (4.:) 6:.1 (3.9) 6.:f

(e726;) (e7269)

% nvnkhtns (G HH)

(HK[H)

94.8 99.2 E[

(e79:9) (e79;9)

Rfsf ba

Cakuebfkhe (%)6

33.0 (:;.2) 39.3 (::.8) E[

(e739:) (e7902)

E Agjrhneas

trfescarhbns6

6,9 (0.2) 6.9 (0.2) E[

A E,@$* d;?o *+q_Q__AQ

;,R#",\ ,' *&Q !"# %&'()*Q P__jfPJ[B_NBQ

?l-*-$*


36/65

Knrhcnmmhtrnphe Fmcf610 !i

Puraine:00 HQ/b

% ba BhcaraekhfAsthgfbf Fjsnmutf

(81% KH)

(e7913) (e7910)

E ba Agjfrfzns

Avnmuthvns pnr khkmn

hehkhfbn (%):82 (;4.8) :43 (;4.6) 0.8% (-;.8, 1.9)

(e739:) (e7902)

E ba Agjfrfzns

Avnmuthvns pnrtrfescaraekhf (%)

:82(2;.4) :43(20.3) ;.6% (-:.0, 4.:)

;,R#",\ ,' *&Q !"# %&'()*Q P__jfPJ[B_NBQ

?l-*-$*

4 $@ @


37/65

J,O AC LDKLKH


38/65

4,Z0#$@*@

4 $@ @


39/65

AE*))*,#'2 1 ,' *&Q %,- ./06/&Q P_A_[PA[NN`kNQ

TYE?98 ;? 8O8!HL84

G182T1662581423: ^ ?O>8

?T4Y9?A

dA__ rZ -"#$%"&&$'#"($)* mR2 AK_ D4:#o ABWB u kWB A_WN u KQj 6v_W__A

?T^G^?P

dAK_ rZ -"#$%"&&$'#"($)* mR2 P__ D4:#o ABWk u cWP APWK u NWk 6v_W__A

P;,R#",\ ,' *&Q !"# %&'()*Q P__jfPJ[B_NBQ

4,Z0#$@*@

4 $@ @


40/65

8?O>

! # $ % & ' ( ) * !+

K35:X132-5: U3D>

NGUG182T1662581423: :6T:

,613\:R ?2;N: L`;32;:

%R$ G1358:23Y2;:;2139- :$(,#2,)2$/$&$@*@f '0="#,2 "RM#$-"2W @, &* =*=*W w',#"W .$(7l2$2 " .$("'M&*="f

:,="##*Z$* R*Z$)*& *)"#=*& d)" =,)2'#0*&o 2$) -*02* -")"-$@*e@$*Z)"2


41/65

8?O>

! # $ % & ' ( ) * !+

K35:X132-5: U3D>

NGUG182T1662581423: :6T:

" !*)-,&*#

U3D>S:

" ;,2,)-*@,)*# -") GZ")$2'*2 @, &* ^)9:" !"*2


42/65

JE,DH


43/65

! # $ % & ' ( ) * !+

! # $ % & ' ( ) * !+

!")'#"& @, &* ?2


44/65

!")'#"& @, &* ?2


45/65

!")'#"& @, &* ?2


46/65

JE,DH


47/65

6#"Z#*=*-$7) @,& '#*'*=$,)'"

6 $7 @ & ' ' $ '


48/65

6#"Z#*=*-$7) @,& '#*'*=$,)'"

L., $)-$@,)-, "% ""-\', #,'#$,R*&2 ") z,,X,)@2

-*) /, 2$Z)$l-*)'&\ #,@0-,@ *)@ 40)@*\ ""-\',

#,'#$,R*&2 -*) *&z*\2 /, *R"$@,@Q

6 $7 @ & ' ' $ '


49/65

! # $ % & ' ( ) * !+7f: G2;61

! # $ % & ' ( ) * !+7f: ,-./06:;2j3

! # $ % & ' ( ) * !+7f: G2;61

! # $ % & ' ( ) * !+7f: ,-./06:;2j3 ! # $ % & ' ( ) * !+

6#"Z#*=*-$7) @,& '#*'*=$,)'"

6 $7 @ & ' ' $ '


50/65

! # $ % & ' ( ) * !+7f: G2;61

! # $ % & ' ( ) * !+7f: ,-./06:;2j3

! # $ % & ' ( ) * !+7f: G2;61

! # $ % & ' ( ) * !+7f: ,-./06:;2j3 !!

6#"Z#*=*-$7) @,& '#*'*=$,)'"

6 $7 @ & ' ' $ '


51/65

6#"Z#*=*-$7) @,& '#*'*=$,)'"

!")'#"& @, &* ?2


52/65

! # $ % & ' ( ) * !+

!")'#"& @, &* ?2


53/65

!")'#"& @, &* ?2


54/65

!")'#"& @, &* ?2


55/65

E,)"# '*2* @, ,=/*#*>"

E*\"#


56/65

! # $ % & ' ( ) * !+

KX132-5: U3D> iY2:821d

!! !##! ## #$ #% #& #' #( #)

?O> NGUG182T1662581423: :6T: ?O> NGUG182T1662581423: :6T:

G182T1662581423 :6T: 23 : 613X U3D> :X132-5 48151;16V 4811T 1T ;13;945 582:6

:@1 !-F .J&(KB AF +)')C6IDH)*)()C6I ,F O61L&M !F -@//@&(1M ,F G&C()&K +

D,#


57/65

JL


58/65

69?!H84 GYL89H{G;84

?V8TOG AK_ =-Z b

A U?9HT^G 69Q

6QOQV[ KB_WJA|` 6QOQ6[ KcNWBP|` 6QOQ6Q`HOG[ N_jWkk|

.}([eezzzQ=2@Q,2e(#"@0-'"2el-.*2`',-)$-*2ep~?&")R*~AK_~=-ZQ(@%

!"2', ?-")7=$-"


59/65

L., 02, "% ^)9: *Z")$2' $) HOD (#"'"-"&2L., 20#R,\ $)-&0@,2 #,("#'2 %#"= PkB -,)'#,2 z"#&@z$@, (,#%"#=$)Z AKAW___ HOD -\-&,2*))0*&&\Q

!"2', ?-")7=$-"

!"2', ?-")7=$-"


60/65

A

E*))*,#'2 1 ,' *&Q %,- ./06/&Q P_A_[PA[NN`kNQ

TYE?98 ;? 8O8!HL84G182T1662581423: ^ ?O>8

?T4Y9?A

dA__ rZ -"#$%"&&$'#"($)* mR2 AK_ D4:#o ABWB u kWB A_WN u KQj 6v_W__A

?T^G^?P

dAK_ rZ -"#$%"&&$'#"($)* mR2 P__ D4:#o

ABWk u cWP APWK u NWk 6v_W__A

P;,R#",\ ,' *&Q !"# %&'()*Q P__jfPJ[B_NBQ

!"2', ?-")7=$-"

!"2', ?-")7=$-"


61/65

0D4:

:E^`.(

D4:#:E^`.( dAK_ekKo

?&")R* AK_

D4:# dPPKo

D4:#V:#

E89;21 G1/4:8:.\: i##& A


62/65

T" $)%,#$"#$@*@ ABj_ (*-$,)',2 #*)@"=$>*@*2 BB -&$)$-*2 @, Y4G BK`JP *C"2 4"&" AK_ rZ $)-&0\,)@" =03,#,2 n K_ XZ ^#0(" -")'#"& B__ YH D4:#

Knrhcnmmhtrnphe Fmcf610 !i

Puraine;00 HQ/b

Aii Zatrhavab 60.9 (9.:) 60.; (3.4) +0.1 \0.: tn 6.:W

Shtfm Praiefeky :;,8 % :3,8 % ;.0% \9.2 tn 6.2W

Neinhei Praiefeky ::,: % :2,0 % 6.8% \-3.6 tn :.;W

!"2', ?-")7=$-"

!"2', ?-")7=$-"


63/65

0D4:

:E^`.(

D4:#:E^`.( dAK_eAK_o

?&")R* AK_

D4:#

D4:#V:#

E89;21 G1/4:8:.\: i$++ A


64/65

!+*)('&%$#!

O./06:.13 Y:_-

?O>:

;.

\25_

LN98:490.;

5N89-N16Y

G182T1662581423 :6T:

8?O>$4,)-$&&"$?l-*>$!7="@"$4,Z0#"$D&,g$/&,$?-")7=$-"

!")-&02$"),2


65/65

H)2'1,#)*/,0;#V&*-,#

zzzQ$)2

joaquín llacer - corifolitropina en la paciente habitual - ii simposio reproducción asistida...

Documents